We are delighted to announce that the following product range Bladder EpiCheck® from Nucleix is now available from Medical Supply Company.
Nucleix has launched to the market a non-invasive test for bladder cancer, that allows urologists to better monitor patients.
The assay is based on the analysis of 15 DNA methylation biomarkers for the detection of bladder cancer, reducing the need for invasive procedures.
Epcicheck has been chosen as the standard of care for Radoud University Medical Centre (Netherlands), under the direction of Prof. Fred Witjes. For more information on the Bladder EpiCheck® Click here
